NovoSeven RT
Drug
Novo Nordisk Inc
Total Payments
$858,247
Transactions
1,079
Doctors
479
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $113,188 | 85 | 61 |
| 2019 | $262,874 | 173 | 76 |
| 2018 | $287,312 | 366 | 202 |
| 2017 | $194,872 | 455 | 256 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $437,370 | 130 | 51.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $265,124 | 59 | 30.9% |
| Travel and Lodging | $130,150 | 189 | 15.2% |
| Food and Beverage | $25,080 | 689 | 2.9% |
| Education | $522.70 | 12 | 0.1% |
Top Doctors Receiving Payments for NovoSeven RT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatric Hematology-Oncology | Los Angeles, CA | $82,208 | 33 |
| , M.D | Hematology | Los Angeles, CA | $69,360 | 44 |
| , M.D | Internal Medicine | Memphis, TN | $61,500 | 41 |
| , MD | Pediatric Hematology-Oncology | Danbury, CT | $58,796 | 41 |
| Craig Kessler | Hematology & Oncology | Washington, DC | $46,128 | 22 |
| , M.D | Internal Medicine | Houston, TX | $44,487 | 17 |
| , MD | Pediatric Hematology-Oncology | New Orleans, LA | $43,665 | 34 |
| , MD | Pediatric Hematology-Oncology | Milwaukee, WI | $33,571 | 17 |
| , M.D | Pediatrics | Orlando, FL | $30,898 | 18 |
| , MD | Hematology | Iowa City, IA | $25,837 | 6 |
| , M.D | Pediatric Hematology-Oncology | San Juan, PR | $25,039 | 10 |
| , MD | Pediatric Hematology-Oncology | Boston, MA | $21,784 | 5 |
| , MD | Pediatric Hematology-Oncology | Memphis, TN | $19,606 | 6 |
| , MD | Hematology & Oncology | Chapel Hill, NC | $18,436 | 5 |
| , MD | Pediatrics | Detroit, MI | $14,133 | 8 |
| , MD | Pediatric Hematology-Oncology | Ann Arbor, MI | $14,048 | 5 |
| , MD | Emergency Medicine | Washington, DC | $13,840 | 4 |
| , M.D | Pediatrics | Chicago, IL | $12,512 | 12 |
| , MD | Pediatrics | Detroit, MI | $9,720 | 3 |
| , M.D | Pediatrics | Peoria, IL | $8,661 | 8 |
| , MD | Clinical Pathology/Laboratory Medicine | Atlanta, GA | $8,199 | 6 |
| , MD | Pediatrics | Washington, DC | $7,843 | 7 |
| , MD | Hematology & Oncology | New York, NY | $7,158 | 6 |
| , MD | Hematology | Stanford, CA | $6,720 | 5 |
| , MD, PHD | Vascular Neurology | San Diego, CA | $6,634 | 3 |
Ad
Manufacturing Companies
- Novo Nordisk Inc $639,760
- Novo Nordisk Health Care AG $172,390
- Novo Nordisk AS $46,097
Product Information
- Type Drug
- Total Payments $858,247
- Total Doctors 479
- Transactions 1,079
About NovoSeven RT
NovoSeven RT is a drug associated with $858,247 in payments to 479 healthcare providers, recorded across 1,079 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.
Payment data is available from 2017 to 2020. In 2020, $113,188 was paid across 85 transactions to 61 doctors.
The most common payment nature for NovoSeven RT is "Consulting Fee" ($437,370, 51.0% of total).